Literature DB >> 20674766

A review of Charcot neuroarthropathy of the midfoot and hindfoot: what every radiologist needs to know.

Corrie M Yablon1, Naven Duggal, Jim S Wu, Sanjay K Shetty, Fui Dawson, Mary G Hochman.   

Abstract

Charcot neuroarthropathy (CN) occurs commonly in diabetic patients in the joints of the foot and ankle. Radiologists may be the first to suggest the diagnosis of CN and can facilitate prompt intervention and treatment if they are aware of the radiographic manifestations of CN and the signs of progression of disease. Radiologists should also become aware of the evolving treatment of the disease as focus is shifting toward early surgical intervention and limb salvage rather than amputation. Knowledge of preoperative assessment, the types of surgeries performed, and some of the encountered postoperative complications enable the radiologist to facilitate timely intervention by our surgical colleagues and be a valuable member of the management team. 2010 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20674766     DOI: 10.1067/j.cpradiol.2009.06.001

Source DB:  PubMed          Journal:  Curr Probl Diagn Radiol        ISSN: 0363-0188


  3 in total

Review 1.  Neuropathic osteoarthropathy with and without superimposed osteomyelitis in patients with a diabetic foot.

Authors:  Antonio Leone; Victor N Cassar-Pullicino; Alessia Semprini; Laura Tonetti; Nicola Magarelli; Cesare Colosimo
Journal:  Skeletal Radiol       Date:  2016-02-17       Impact factor: 2.199

2.  Management of diabetic neuropathic foot and ankle malunions and nonunions.

Authors:  John J Stapleton
Journal:  Diabet Foot Ankle       Date:  2011-05-11

3.  Developing an evidence-based clinical pathway for the assessment, diagnosis and management of acute Charcot Neuro-Arthropathy: a systematic review.

Authors:  Tamara E Milne; Joseph R Rogers; Ewan M Kinnear; Helen V Martin; Peter A Lazzarini; Thomas R Quinton; Frances M Boyle
Journal:  J Foot Ankle Res       Date:  2013-07-30       Impact factor: 2.303

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.